SPH Notice - Asset Management Limited

1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
To NZX Limited
and
To Promisia Healthcare Limited
Relevant event being disclosed: Movement of 1% or more in substantial holding
Date of relevant event: 30 October 2026
Date this disclosure made: 30 October 2026
Date last disclosure made: 6 October 2026
Substantial product holder(s) giving disclosure
Full name(s): Asset Management Limited
Summary of substantial holding
Class of quoted voting products: Warrants (PHLWA) in Promisia Healthcare Limited
Summary for Asset Management Limited
For this disclosure,—
(a) total number held in class: 9,000,000
(b) total in class: 27,935,900
(c) total percentage held in class: 32.217%
For last disclosure,—
(a) total number held in class: 15,000,000
(b) total in class: 27,947,900
(c) total percentage held in class: 53.671%
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure:
As disclosed in a previous notice dated 6 October 2026, on 5 October 2026 Asset
Management Limited entered into an unconditional agreement for the sale and purchase of
warrants with Gould Holdings Limited for the sale of 6,000,000 warrants in Promisia
Healthcare Limited for $0.25 per warrant. Settlement of this transaction has occurred on
the date of this notice.

2
Details after relevant event
Details for Asset Management Limited
Nature of relevant interest(s): registered holder of warrants in Promisia Healthcare Limited
For that relevant interest,—
(a) number held in class: 9,000,000
(b) percentage held in class: 32.217%
(c) current registered holder(s): Asset Management Limited
(d) registered holder(s) once transfers are registered: N/A
For a derivative relevant interest, also—
(a) type of derivative: N/A
(b) details of derivative: N/A
(c) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Additional information
Address(es) of substantial product holder(s): 7 Fendalton Road, Fendalton, Christchurch
8014, New Zealand
Contact details: Matt Yates, 04 499 3280, matt.yates@duncancotterill.com
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: Gould Holdings Limited
Certification
I, Tony Mortensen, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure
by all persons for whom it is made.